The Vessel Has Been Recanalized: Now What?

Area of Science:

• Neuroscience
• Neurology
• Biomedical Engineering

Background:

• Acute ischemic stroke treatment focuses on rapid recanalization via thrombolysis and mechanical clot removal.
• Successful recanalization does not guarantee reperfusion due to microvascular obstruction.
• Post-recanalization complications include blood-brain barrier breakdown, reperfusion injury, excitotoxicity, and brain atrophy, impairing patient outcomes.

Purpose of the Study:

• To highlight the gap in understanding post-recanalization tissue damage mechanisms in acute ischemic stroke.
• To emphasize the need for better identification of effective cerebroprotectants.
• To propose a research strategy for optimizing cerebroprotection trial design.

Main Methods:

• Review of current clinical practices and challenges in acute ischemic stroke treatment.
• Discussion of known post-recanalization tissue damage pathways.
• Proposal for serial human MRI and primate animal studies.

Main Results:

• Current knowledge is insufficient to reliably identify promising cerebroprotectants.
• Lack of understanding hinders effective clinical trial design for cerebroprotective agents.
• Serial human MRI and primate studies are proposed to address these knowledge gaps.

Conclusions:

• Further research is critical to elucidate post-recanalization tissue damage mechanisms.
• Optimizing cerebroprotection trial design requires a deeper understanding of these mechanisms.
• Accelerating the translation of cerebroprotective agents necessitates robust preclinical and clinical investigations.